Results for tag: "Abaloparatide"

Abaloparatide is a synthetic peptide hormone used to treat osteoporosis in postmenopausal women. It is a member of the parathyroid hormone family and works by stimulating bone formation and increasing bone mineral density. Abaloparatide is administered as a subcutaneous injection and is typically used in combination with other medications to reduce the risk of fractures. Abaloparatide is classified as an endocrine and metabolic disorder drug, and is used to treat a variety of conditions related to bone health. It is used to reduce the risk of fractures in postmenopausal women with osteoporosis, as well as to treat osteoporosis in men and women with certain conditions such as glucocorticoid-induced osteoporosis. Abaloparatide is also used to treat Paget's disease of bone, a condition characterized by abnormal bone remodeling. Several companies are involved in the Abaloparatide market, including Amgen, Radius Health, and Eli Lilly. Amgen is the manufacturer of the drug, while Radius Health and Eli Lilly are involved in the marketing and distribution of the drug. Show Less Read more